Monica Arnedos Selected Research

Ketones

1/2021

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Arnedos Research Topics

Disease

31	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2007
21	Neoplasms (Cancer) 01/2023 - 12/2007
3	Triple Negative Breast Neoplasms 01/2023 - 07/2012
2	Disease Progression 04/2024 - 01/2020
2	Neoplasm Metastasis (Metastasis) 03/2023 - 02/2011
2	Lobular Carcinoma 07/2014 - 02/2011
1	Brain Neoplasms (Brain Tumor) 04/2024
1	Exanthema (Rash) 10/2021
1	Mucositis 10/2021
1	COVID-19 01/2021
1	Aneuploidy (Aneuploid) 11/2019
1	Rare Diseases (Rare Disease) 01/2014
1	Carcinoma (Carcinomatosis) 02/2011
1	Pain (Aches) 11/2008
1	Sepsis (Septicemia) 11/2008
1	Neutropenia 11/2008
1	Infertility (Sterility) 08/2008

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2011
6	Trastuzumab (Herceptin)FDA Link 04/2024 - 02/2014
6	Hormones (Hormone)IBA 01/2024 - 11/2007
5	Estrogen ReceptorsIBA 01/2022 - 07/2012
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 06/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2012
3	Everolimus FDA Link 01/2024 - 10/2017
3	TOR Serine-Threonine KinasesIBA 01/2024 - 10/2017
3	Letrozole (Femara)FDA LinkGeneric 11/2014 - 11/2007
2	exemestane (Aromasin)FDA Link 01/2024 - 11/2007
2	Taxoids (Taxanes)IBA 01/2023 - 11/2019
2	GenieIBA 01/2022 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 07/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 11/2013
2	Fulvestrant (Faslodex)FDA Link 01/2020 - 10/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 11/2008
2	Phenobarbital (Luminal)FDA Link 10/2019 - 05/2015
2	Epidermal Growth Factor (EGF)IBA 05/2016 - 02/2014
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2013 - 07/2012
2	Aromatase InhibitorsIBA 06/2012 - 11/2007
1	trastuzumab deruxtecanIBA 04/2024
1	tucatinibIBA 04/2024
1	Capecitabine (Xeloda)FDA Link 04/2024
1	Androgen Antagonists (Antiandrogens)IBA 12/2023
1	Androgen Receptors (Androgen Receptor)IBA 12/2023
1	pertuzumabIBA 03/2023
1	AlpelisibIBA 01/2022
1	ribociclibIBA 01/2022
1	rucaparibIBA 12/2021
1	durvalumabIBA 01/2021
1	KetonesIBA 01/2021
1	AntibodiesIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	neratinibIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2019
1	palbociclibIBA 10/2019
1	CyclinsIBA 10/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2017
1	MTOR InhibitorsIBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	LigandsIBA 03/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2012
1	human ERBB2 proteinIBA 07/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2012
1	Formaldehyde (Formol)FDA Link 06/2012
1	ParaffinIBA 06/2012
1	Aromatase (CYP19)IBA 06/2012
1	Cyclin-Dependent Kinase 2IBA 03/2012
1	Monoclonal AntibodiesIBA 02/2011
1	CateninsIBA 02/2011
1	Cadherins (E-Cadherin)IBA 02/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2008
1	Goserelin (Zoladex)FDA Link 08/2008
1	Tamoxifen FDA LinkGeneric 12/2007
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2007

Therapy/Procedure

15	Therapeutics 04/2024 - 04/2007
5	Neoadjuvant Therapy 11/2019 - 11/2008
4	Adjuvant Chemotherapy 05/2015 - 08/2008
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2012
2	Precision Medicine 12/2015 - 01/2014
1	Ketogenic Diet 01/2021
1	Maintenance Chemotherapy 01/2021
1	Time-to-Treatment 11/2019
1	Conservative Treatment 07/2014
1	Mastectomy (Mammectomy) 07/2014
1	Aftercare (After-Treatment) 08/2013
1	Treatment Delay 11/2008
1	Drug Tapering 11/2008